Your browser doesn't support javascript.
The impact of COVID-19 pandemic on healthcare associated infections: A teaching hospital experience.
Obeidat, Haneen; El-Nasser, Ziad; Amarin, Zouhair; Qablan, Almutazballah; Gharaibeh, Faris.
  • Obeidat H; Medical Laboratory Specialist/Clinical Microbiology and Immunology, Medlabs Consultancy Group, Irbid, Jordon.
  • El-Nasser Z; Department of Pathology and Microbiology, Jordan University of Science and Technology, Irbid, Jordon.
  • Amarin Z; Department of Obstetrics and Gynecology, Jordan University of Science and Technology, Irbid, Jordon.
  • Qablan A; Department of Medicine, Jordan University of Science and Technology, Irbid, Jordon.
  • Gharaibeh F; Department of Medicine, Jordan University of Science and Technology, Irbid, Jordon.
Medicine (Baltimore) ; 102(15): e33488, 2023 Apr 14.
Article in English | MEDLINE | ID: covidwho-2301106
ABSTRACT
Coronavirus disease-19 (COVID-19) is a global pandemic, with a high capability of contagious distribution, where national secondary and co-infections characterization are lacking. The objective of this study was to assess the impact of the COVID-19 pandemic on infection rates among patients admitted to the intensive care units at King Abdullah University Hospital, profiling the drug resistance rates nationally. This is a cross-sectional study of COVID-19 associated infections that was conducted at a teaching hospital, in the north of Jordan. It included all COVID-19 patients who were admitted to intensive care units during the first and second pandemic waves. Data on age, gender, length of stay, co-morbidities, co-infections and sensitivity to antibiotics were retrospectively collected from the hospital information database. Statistical analyses were performed using SPSS software. A total of 589 COVID-19 patients were included, of whom 20% developed bacterial associated infections. The ratio of bacterial co-infection to secondary infections was 18. Gram-negative bacteria, Acinetobacter baumannii (40.1%), Eschericia coli (17.5%), Klebsiella pneumonia (6.8%), and Pseudomonas aeruginosa (5.1%) were the most abundant isolated species. The detection rates of E coli (ESBL), K pneumonia (ESBL), A baumannii (CRO), P aeruginosa (CRO), S aureus (MRSA) were 52%, 67%, 97%, 44%, and 67%, respectively.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Bacterial Infections / Cross Infection / Coinfection / COVID-19 Type of study: Diagnostic study / Experimental Studies / Observational study / Randomized controlled trials Limits: Humans Language: English Journal: Medicine (Baltimore) Year: 2023 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Bacterial Infections / Cross Infection / Coinfection / COVID-19 Type of study: Diagnostic study / Experimental Studies / Observational study / Randomized controlled trials Limits: Humans Language: English Journal: Medicine (Baltimore) Year: 2023 Document Type: Article